Creative Planning Mannkind Corp Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Mannkind Corp stock. As of the latest transaction made, Creative Planning holds 118,418 shares of MNKD stock, worth $831,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares

118,418

Previous 132,777 10.81%

Holding current value

$831,294

Previous $693,000 7.22%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$5.01 - $6.7 $71,938 - $96,205	-14,359 Reduced 10.81%	118,418 $743,000
Q2 2024 Aug 15, 2024	BUY	$4.05 - $5.43 $160,618 - $215,348	39,659 Added 42.59%	132,777 $693,000
Q1 2024 May 10, 2024	SELL	$3.25 - $5.27 $6,285 - $10,192	-1,934 Reduced 2.03%	93,118 $421,000
Q4 2023 Feb 14, 2024	BUY	$3.34 - $4.29 $394 - $506	118 Added 0.12%	95,052 $345,000
Q3 2023 Nov 16, 2023	SELL	$3.91 - $5.45 $57,844 - $80,627	-14,794 Reduced 13.48%	94,934 $392,000
Q2 2023 Jul 21, 2023	BUY	$3.72 - $4.79 $2,708 - $3,487	728 Added 0.67%	109,728 $446,000
Q1 2023 May 15, 2023	BUY	$3.95 - $5.63 $33,851 - $48,249	8,570 Added 8.53%	109,000 $446,000
Q4 2022 Feb 10, 2023	SELL	$3.02 - $5.37 $27,898 - $49,608	-9,238 Reduced 8.42%	100,430 $529,000
Q3 2022 Nov 03, 2022	BUY	$2.99 - $4.35 $14,866 - $21,628	4,972 Added 4.75%	109,668 $339,000
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $47,779 - $85,359	-17,895 Reduced 14.6%	104,696 $399,000
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $4,658 - $7,912	-1,778 Reduced 1.43%	122,591 $451,000
Q4 2021 Feb 11, 2022	BUY	$4.05 - $5.37 $18,411 - $24,412	4,546 Added 3.79%	124,369 $543,000
Q3 2021 Nov 10, 2021	BUY	$3.89 - $5.48 $1,945 - $2,740	500 Added 0.42%	119,823 $521,000
Q2 2021 Aug 04, 2021	SELL	$3.61 - $5.45 $3,761 - $5,678	-1,042 Reduced 0.87%	119,323 $650,000
Q1 2021 Apr 30, 2021	SELL	$3.14 - $6.14 $154,246 - $301,615	-49,123 Reduced 28.98%	120,365 $472,000
Q4 2020 Jan 29, 2021	SELL	$1.79 - $4.04 $764 - $1,725	-427 Reduced 0.25%	169,488 $530,000
Q3 2020 Nov 05, 2020	BUY	$1.56 - $2.08 $936 - $1,248	600 Added 0.35%	169,915 $319,000
Q2 2020 Jul 23, 2020	SELL	$0.94 - $2.21 $470 - $1,105	-500 Reduced 0.29%	169,315 $296,000
Q3 2019 Nov 01, 2019	SELL	$1.04 - $1.44 $101,292 - $140,251	-97,397 Reduced 36.45%	169,815 $212,000
Q2 2019 Jul 26, 2019	BUY	$1.09 - $1.88 $32,222 - $55,576	29,562 Added 12.44%	267,212 $307,000
Q1 2019 Apr 24, 2019	SELL	$1.14 - $2.25 $3,310 - $6,534	-2,904 Reduced 1.21%	237,650 $468,000
Q4 2018 Feb 01, 2019	SELL	$1.02 - $2.05 $1,405 - $2,824	-1,378 Reduced 0.57%	240,554 $255,000
Q3 2018 Oct 25, 2018	SELL	$1.01 - $2.19 $3,737 - $8,103	-3,700 Reduced 1.51%	241,932 $443,000
Q2 2018 Jul 20, 2018	BUY	$1.59 - $2.38 $4,770 - $7,140	3,000 Added 1.24%	245,632 $467,000
Q1 2018 Apr 18, 2018	BUY	$2.28 - $3.8 $2,015 - $3,359	884 Added 0.37%	242,632 $553,000
Q4 2017 Jan 17, 2018	BUY	$2.28 - $6.71 $68,229 - $200,796	29,925 Added 14.13%	241,748 $561,000
Q3 2017 Oct 17, 2017	BUY	$1.15 - $2.29 $243,596 - $485,074	211,823	211,823 $460,000

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Mannkind Corp Transaction History